3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Toxemia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Myocarditis
1
Muscle Weakness
1
Melanoma
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma in Situ
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
14
Cisplatin
13
Specimen Handling
11
Magnetic Resonance Spectroscopy
7
Brachytherapy
7
Bevacizumab
7
Radiotherapy
6
atezolizumab
5
Platinum
5
Paclitaxel
5
Nivolumab
5
Human Papillomavirus DNA Tests
5
Gemcitabine
5
Colposcopy
5
Carboplatin
5
Blood Specimen Collection
5
Radiation
4
Fulvestrant
4
lenvatinib
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Drug Therapy
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
zimberelimab
2
tisotumab vedotin
2
spartalizumab
2
palbociclib
2
camrelizumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Positron-Emission Tomography
×
90 days
×
Clear all
No trials found.